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The treatment of occlusive disease of the great
vessels has evolved over the past several decades. In
the 1950s and 1960s, reports of transthoracic
innominate artery endarterectomy and bypass graft-
ing showed its technical feasibility.1 In attempts to
decrease the morbidity and mortality associated with
direct great vessel reconstructions, extra-anatomic
means of revascularization were introduced.1,2
Recent series of extra-anatomic reconstructions have
documented acceptable mortality rates.3,4 However,
not all patients have an anatomic distribution of dis-
ease amenable to these approaches. The patency of
some of these extra-anatomic reconstructions for
innominate artery disease is suspect because of the
subcutaneous, trans-sternal routes of reconstruction.
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Objective: Great vessel reconstruction for arterial occlusive disease has been shown to be
a durable procedure. The purpose of this report is the examination of the influence of
cause and risk factors on outcomes for the identification of patients who may be better
treated with endovascular techniques or other surgical approaches.
Methods: Data for patients who underwent aortic-origin great vessel reconstruction
between 1988 and 1998 were reviewed. The data were analyzed with Fisher exact test,
life-table analysis, and log-rank test.
Results: Ninety-two vessels underwent revascularization in 58 patients (15 men, 43
women; mean age, 54 years; age range, 20 to 82 years). Etiology was atherosclerosis
obliterans (n = 40; 69%), Takayasu’s arteritis (n = 13; 22%), radiation arteritis (RA; n =
4; 7%), and mediastinal fibrosis (n = 1; 2%). The symptoms were cerebrovascular (n =
25), upper extremity (n = 8), or both (n = 23), and two patients were asymptomatic.
The bypass grafting was performed with single-limb synthetic grafts (n = 23) or grafts
plus side arms (n = 28). Seven patients underwent innominate endarterectomy. The
mean follow-up period was 45 months (range, 0 to 126 months). The perioperative
stroke (n = 4; 7%) and death (n = 2; 3%) rates were not related to the cause of disease.
The patients with creatinine levels of 2 or more (n = 4) had a combined perioperative
stroke/death rate of 50% (vs 7% for patients with healthy creatinine levels; P < .05). The
patients with hypercoagulable states (ie, thrombophilia; n = 6) had an increased periop-
erative stroke rate (33% vs 4% for patients without hypercoagulable states; P < .05) and
an increased late thrombosis rate. The primary and secondary graft patency rates at 5
years were 80% ± 7% and 91% ± 5%, respectively. Patients with RA had a greater risk of
stroke or death at 3 years (33% free of stroke or death vs 79% for patients with athero-
sclerosis obliterans and 92% for patients with Takayasu’s arteritis; P = .02) and an
increased major late infection rate (50% vs 2% for all others; P = .01).
Conclusion: Patients with thrombophilia and renal insufficiency have increased periop-
erative stroke and stroke/death rates, respectively. Patients with RA have an increased
incidence rate of late major infection, which directly contributes to an increased rate of
stroke or death. Patients with thrombophilia have an increased rate of late graft throm-
bosis. These patient conditions should be approached cautiously, and some patients may
benefit from endovascular therapy. (J Vasc Surg 2000;31:260-9.)
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supra-aortic occlusive lesions have documented
acceptable perioperative stroke and death rates of 5%
to 8%, with excellent long-term patency and stroke-
free survival rates.5,6 In distinction, some authors are
now advocating endovascular therapy as the pre-
ferred primary treatment.7
Occlusive disease of the great vessels is uncom-
mon enough that a large randomized trial is unlike-
ly. Each reported series represents a heterogeneous
subset of patients who may or may not be compara-
ble with other reported patients. For example, all the
patients in the study by Kieffer et al5 had atheroscle-
rosis obliterans (ASO), 22% were asymptomatic, and
most were male. In contrast, most of our patients
have been women, few were asymptomatic, and the
etiology was mixed.8 Given this variability, it is
unlikely that one procedure can be proven to be
optimal for all patients. In the consideration of
whether direct trans-sternal reconstruction, extra-
anatomic bypass grafting, or endovascular approach
is best in any given patient, the risks, benefits, and
limitations of each of these procedures should be
known. The purpose of this report is to provide
additional contemporary data on the morbidity,
mortality, and long-term results of trans-sternal
revascularization of the great vessels and specifically
to identify which subgroups of patients might have
poor early and late outcomes with aortic-origin
reconstruction and might therefore benefit from an
alternative surgical or endovascular approach.
PATIENTS AND METHODS
During the period between 1988 and 1998, 58
consecutive patients (15 men and 43 women; mean
age, 54 years; age range, 20 to 82 years) underwent
direct trans-sternal aortic-origin reconstruction of
92 great vessels for occlusive disease at the Mayo
Clinic in Rochester, Minn. Data were collected by
means of retrospective chart review. Any patient who
was not seen in the past 6 months was contacted by
phone for assessment of persistent or recurrent
symptoms. Objective patency was assessed with arte-
riography (including intravenous digital subtraction
techniques), duplex ultrasound scanning, or com-
puter tomographic or magnetic resonance imaging.
All the patency data that are reported are on the
basis of objective radiographic imaging criteria only.
The cardiovascular risk factors identified before
surgery included tobacco use (n = 51; 88%), hyper-
lipidemia (n = 42; 72%), distant history of stroke or
transient ischemic attacks (n = 31; 53%), peripheral
vascular disease (n = 30; 52%), hypertension (n = 27;
47%), known coronary artery disease (n = 26; 45%),
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diabetes mellitus (n = 8; 14%), and renal insufficien-
cy (creatinine level ≥2.0; n = 4; 7%). No patient
required dialysis.
The presenting symptoms were cerebrovascular
(n = 25), upper extremity (n = 8), or both (n = 23).
Two patients were asymptomatic: one underwent
simultaneous coronary artery bypass grafting, and
the other had rapidly progressive hemodynamically
significant lesions at the carotid bifurcations in addi-
tion to great vessel disease. Both had innominate
artery lesions of > 80% stenosis. The cerebrovascular
symptoms included transient ischemic attacks,
amaurosis fugax, or both (n = 22), global ischemia
(n = 11), stroke within the last 3 months (n = 8), or
vertebrobasilar insufficiency (n = 7). Of the patients
with upper extremity symptoms, 21 had claudica-
tion, eight had microembolization, and two had rest
pain.
All the patients underwent preoperative trans-
femoral arteriography. The most frequent cause of
occlusive disease was ASO (n = 40; 69%). Thirteen
patients (22%) had Takayasu’s arteritis (TA), four
patients (7%) had radiation arteritis (RA), and one
patient had fibrosing mediastinitis combined with
ASO (2%). This final patient was included in the
ASO group for further analysis. High-grade occlu-
sive lesions (70% to 100%) of multiple great vessels
were present in 71% of the patients (n = 41). High-
grade carotid bifurcation lesions (70% to 100%)
were identified in 34% of the patients (n = 20). The
degree of stenosis of intrathoracic arterial lesions was
determined from diameter-reduction on arteriogra-
phy, and cervical lesions were graded with duplex
scanning.
Six patients were found to have hypercoagulable
states, or in more current terminology, throm-
bophilia, either before surgery (n = 1) or after
surgery (n = 5). Four patients were protein C or pro-
tein S deficient, one patient was antithrombin III
deficient, and a final patient had a documented fac-
tor V Leiden mutation. Obviously, testing changed
and became more sophisticated and accurate
throughout the years of this study (eg, the diagnosis
of a factor V Leiden mutation was not possible even
several years ago). All the patients underwent testing
near the seminal event. Those patients undergoing
heparin or warfarin sodium therapy were retested
several months later to obviate the false-positive
effects of those drugs. Only two other patients
underwent testing for hypercoagulable states, and
both of these tests had negative workup results.
Thus, the denominator for patients with document-
ed thrombophilia is unknown.
All the reconstructions were performed through
median sternotomies with appropriate extensions or
counter incisions as needed. The left brachiocephal-
ic vein was ligated and divided in seven patients. All
the grafts were 7-mm, 8-mm, and 10-mm polyester
grafts and originated from the ascending aorta.
When multiple vessels were reconstructed, separate
7-mm or 8-mm polyester side arms were added.
Single-vessel reconstructions were performed in 25
patients (23 grafts, two endarterectomies), two-ves-
sel reconstructions were performed in 32 patients
(27 graft, five endarterectomies), and a three-vessel
reconstruction was performed in a single patient
(innominate, left common carotid, and left subcla-
vian arteries with grafting). The target vessels
included the innominate artery (n = 36), the left
carotid artery (n = 25; carotid includes common,
internal, and external), the right carotid artery (n =
16), the left subclavian artery (n = 8) and the right
subclavian artery (n = 7). The most frequently per-
formed reconstruction was aorto-innominate artery
bypass grafting (n = 17; 29%). Innominate endar-
terectomy alone was performed in seven patients
(12%). Eight concomitant carotid bifurcation
endarterectomies were performed in seven patients.
Nine patients had undergone prior carotid end-
arterectomies, five had undergone prior extra-
anatomic reconstructions for great vessel disease,
and two had undergone prior direct aortic-origin
reconstructions that had failed. One patient had
undergone prior innominate artery angioplasty, and
one had undergone prior subclavian artery angio-
plasty. All the prior operations or angioplasties were
performed at least 4 weeks before the great vessel
reconstruction. Concomitant carotid endarterecto-
my was performed for more than 70% bifurcation
lesions in these seven patients when the great vessel
reconstruction was ipsilateral to the bifurcation
lesion. In general, contralateral carotid bifurcation
endarterectomies (ie, in the absence of proximal
common carotid disease) were performed separately.
The subsequent great vessel reconstructions were
performed as symptoms dictated.
Continuous electroencephalographic monitoring
was used for 56 of the 58 patients. On the basis of
electroencephalographic changes consistent with
cerebral ischemia, six patients required shunt place-
ment. Only one patient underwent a concomitant
bifurcation endarterectomy. The graft anastomosis
was begun, to anchor the graft and the artery, and
intraluminal shunts were placed in the standard
manner after that. Of late, we have relied on cerebral
protection from isoflurane anesthesia, barbiturates,
and relative hypertension. One patient underwent
prophylactic shunting because of an ipsilateral stroke
6 weeks before great vessel reconstruction. Twelve
patients required cardiopulmonary bypass grafting:
10 for simultaneous coronary artery bypass grafting
(CABG), one for aortic arch coarctation repair, and
one for aortic arch aneurysmorrhaphy.
The incidence rate of perioperative complica-
tions was calculated to include any adverse event
within the first 30 days from the date of operation.
The main long-term endpoints analyzed were cumu-
lative rates of primary and secondary patency, stroke,
and death. All the data are reported as mean ± the
standard error of the mean. The categorical data
were compared with Fisher exact test. The survival
and patency rate data were analyzed with the
Kaplan-Meier life-table method and were compared
with the log-rank test. A P value of less than .05 was
considered to be significant.
RESULTS
Initial outcomes. All 58 patients had their
planned reconstructions completed. There was no dif-
ference in the two groups when divided into 5-year
cohorts in regards to death, stroke, combined death
and stroke, and primary graft patency rates. Twenty-
five patients underwent operation in the first half of
the study and 33 in the second half. There were two
perioperative deaths, for a 3% mortality rate. One
patient who underwent simultaneous CABG was
unable to be weaned from bypass grafting and died in
the operating room. The other patient died 2 days
after aorto-right common carotid artery and right sub-
clavian artery reconstruction from extension of an aor-
tic dissection originating at the proximal anastomosis.
There were three acute graft thromboses. One
patient with TA, who initially had a failed aorto-bilat-
eral carotid artery graft and symptoms of global
ischemia, had an asymptomatic thrombosis of the left
limb of an aorto-bilateral external carotid artery bypass
graft. This was not revised. It was believed that the
patent right-sided reconstruction provided enough
circulation to render the patient asymptomatic. Two
other patients had symptomatic graft thromboses.
Both patients were found to be thrombophilic (one
with antithrombin III deficiency and the other with
protein C deficiency). Thrombectomies of these grafts
were performed, and the grafts remained patent at 41
and 52 months. The patients were maintained on war-
farin sodium therapy.
There were two additional perioperative strokes
(cerebrovascular accidents [CVAs]): one from exten-
sion of a previous CVA and the other the result of
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cardiac-source emboli from atrial fibrillation. This
resulted in an overall stroke rate of 7% (n = 4).
Morbidity other than CVA included pneumonia (n =
7; 12%), wound cellulitis (n = 3; 5%), myocardial
infarction (n = 2; 3%), and mediastinal hematoma
that required evacuation (n = 1; 2%).
Other than hypercoagulable states, the other
identified preoperative factor associated with less
favorable early outcomes was renal insufficiency
(creatinine level, ≥2.0; n = 4). In this group, there
was one perioperative CVA and one intraoperative
death, which yielded a combined stroke/death rate
of 50%, as compared with a combined stroke/death
rate of 7% (four of 54) for those with a creatinine
level of less than 2.0 (P < .05). There was no associ-
ation between the cause of the occlusive disease
(ASO vs RA vs TA) and the initial outcomes. The
presence of a hypercoagulable state (n = 6) was asso-
ciated with early graft thrombosis (n = 2; 33% vs 2%
with normal coagulation; P < .05). Both of these
graft thromboses resulted in a thromboembolic
CVA (33% vs 4% with normal coagulation; P < .05).
Neither the number of great vessels involved in
the occlusive process nor the number of arteries
reconstructed affected initial patency or mortality
rates. No specific intraoperative variable, including
use of cardiopulmonary bypass grafting, was associ-
ated with increased morbidity or mortality rates.
The stroke and death rates in patients who required
cardiopulmonary bypass grafting were 8.3% each
and were not significantly increased when compared
with those of patients who did not require bypass
grafting (CVA, 6.5%; death, 2.2%).
Division and oversewing of the left brachio-
cephalic vein tended to increase the incidence rate of
transient perioperative left arm swelling (26% vs 6%),
but this did not reach statistical significance (P =
.09). All the cases responded to elevation. One
patient in each group (oversewn vein and preserved
vein) required warfarin sodium therapy for upper
extremity deep venous thrombosis.
Long-term outcomes. The mean clinical fol-
low-up period was 45 ± 5 months (range, 0 to 126
months). Forty-eight patients were available for
long-term assessment of symptoms. Forty-five
patients (94%) were either asymptomatic (n = 17) or
had a significant improvement in their presenting
symptoms (n = 28).
There were four late graft thromboses in four
patients at 22, 22, 25, and 71 months. One right
external carotid artery graft occlusion and two left
internal carotid graft occlusions were asymptomatic.
An innominate artery graft thrombosis resulted in
recurrent right upper extremity claudication.
There were five late deaths from cardiac causes.
Another patient with RA died (at 10 months) as a
result of a sternal wound infection that first manifest-
ed itself 7 months after trans-sternal revasculariza-
tion. There were two late strokes, one after the resec-
tion of a patent left internal carotid artery graft at 42
Fig 1. Cumulative primary and secondary objective patency rates per graft limb after trans-
sternal aortic-origin great vessel reconstruction. One-year and 5-year patency rates are indicat-
ed. All time points have a standard error of the mean of < 10%.
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months in a patient with RA who had necrosis and
infection of the left neck develop. The other CVA
was caused by cardiac-source embolization. One
additional graft infection occurred at 71 months after
the initial operation in a patient with ASO.
The cumulative primary and secondary 5-year
graft patency rates were 80% and 91%, respectively
(Fig 1). The cumulative survival (Fig 2) and stroke-
free survival rates at 5 years were 88% and 86%,
respectively. The patency rate was not affected by the
type of vessels grafted (innominate vs carotid vs sub-
clavian) or the number of vessels grafted in any one
patient. The patients with ASO, TA, or RA all had
similar primary and secondary patency rates at 3
years. The primary 3-year patency rates were 100%,
82% ± 8%, and 63% ± 16% for RA, ASO, and TA,
respectively (P = NS). The secondary 3-year patency
rates were 100%, 89% ± 7%, and 89% ± 8%, respec-
tively (P = NS). However, the cumulative risk of
stroke or death in patients with RA was significantly
higher (P < .02; Fig 3). The risk of delayed major
infections (>30 postoperative days) was significantly
higher in the RA group (50% vs 2% for others; P =
.01), and this directly contributed to the increased
stroke/death rate.
The final variable that influenced long-term graft
patency was the presence of a hypercoagulable state.
Patients with documented thrombophilia had
decreased primary graft patency with limb thrombo-
sis (Fig 4). However, the 3-year secondary patency
rate (71% ± 17%) and stroke-free survival rate (83%
± 15%) in these patients were not significantly dif-
ferent than those rates in patients without a known
hypercoagulable state (secondary patency rate, 95%
± 4%; stroke-free survival rate, 92% ± 4%), despite
the trends downward in both categories.
DISCUSSION
Trans-sternal reconstruction of the great vessels
for occlusive disease has been shown to be beneficial
for the great majority of patients with ASO and TA,
with acceptable stroke and death rates and excellent
long-term patency and protection from ipsilateral
stroke.6-10 Although most authors currently favor the
bypass grafting technique, endarterectomy in experi-
enced hands remains a good option. The group from
the University of California–San Francisco has used
that technique in 76% of its patients with enviable
results.10 Nonetheless, the stroke and death rates
from some of these more recent series are higher
than what was believed to be the case a decade
ago.5,6,8,9 Berguer et al6 recommended withholding
reconstruction for patients who were asymptomatic
with significant comorbidities. That same group later
also recommended cervical bypass grafting in lieu of
trans-sternal repair whenever feasible.11 The patients
with multiple lesions in that latter series, nonetheless,
had the same risks as the patients who underwent
direct reconstruction with multiple vessel occlusive
disease.6,11
Fig 2. Cumulative survival rate after trans-sternal aortic-origin great vessel reconstruction.
One-year and 5-year survival rates are indicated. All time points have a standard error of the
mean of < 10%.
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The patients who underwent combined CABG
and great vessel reconstruction tended to have high-
er mortality and morbidity rates. This reflects the
known early and long-term deleterious effects of
coronary artery disease on patients with great vessel
disease. Only those patients with critical coronary
stenoses underwent reconstruction at the same time.
For the one patient who underwent operation for an
asymptomatic innominate lesion, the high degree of
stenosis in the face of severe coronary disease war-
Fig 3. Cumulative percent free of stroke or death after trans-sternal aortic-origin great vessel
reconstruction according to etiology of occlusive disease. Patients with radiation arteritis had sig-
nificantly greater rates of stroke or death than patients with Takayasu’s arteritis or atherosclerosis
obliterans (ASO; P < .02). Standard error of the mean of ≥ 10% indicated by dashed line.
Fig 4. Cumulative primary objective graft patency rate per graft limb after trans-sternal aor-
tic-origin great vessel reconstruction, separated by presence or absence of documented hyper-
coagulable state (ie, thrombophilia). Grafts placed in patients with thrombophilia had signifi-
cantly decreased primary patency rates as compared with grafts of patients with no known
coagulation abnormalities (P < .0001). Standard error of the mean of ≥ 10% indicated by
dashed line.
ranted the combined approach. Given the necessity
of a median sternotomy for the treatment of both
disease states, staged operations do not represent an
attractive alternative.
During the last decade, we noticed two groups of
patients with less than satisfactory results after direct
reconstructions: those with RA and those with throm-
bophilia. Our analysis was undertaken to substantiate
or refute those clinical observations. The retrospective
nature of the study and especially the small numbers of
patients who fell into each of these high-risk subsets
(ie, renal insufficiency, RA, and thrombophilia) are all
valid criticisms of this analysis. This paper is, after all, a
10-year retrospective review of patients seen at one
institution. Within that context, we identified those
patients at high risk in our hands and, despite the
shortcomings of the study, we were impressed by the
statistical corroboration of our observations. As a con-
sequence of these findings, we have altered our prac-
tice, whether in providing informed consent to these
particular patients or in considering more strongly
alternative modes of therapy. We do not advocate an
abandonment of direct reconstruction in these subsets
of patients but a reappraisal of the risks and manage-
ment of them. Can patients with renal insufficiency,
thrombophilia, or RA be as well or better treated with
another approach or technique? Whether angioplas-
ty/stenting, cervical bypass grafting, or axillary-axillary
artery bypass grafting will provide improved results for
these higher risk groups remains to be seen and
deserves investigation. These patients may be expected
in general to have increased complications, although
we believe this is the first documentation of the effects
of these specific risk factors on patients who undergo
great vessel reconstruction.
There were four patients, all with ASO, with
serum creatinine levels of 2 or more. In that small
group, however, there was one perioperative CVA and
one death. These two cases accounted for a combined
stroke/death rate of 50% for the four patients with a
creatinine level of 2 or more. Although the number of
patients was quite small, the results were striking and
statistically significant. Our view is that a serum cre-
atinine level of 2 or more, especially combined with
cardiac disease, is a marker for significant comorbidi-
ty and higher operative risks.
One of the two deaths in this series of 58 patients
resulted from the dissection of the ascending aorta
with distal extension. That dissection originated at
the proximal site of aorto-carotid-subclavian artery
grafting. One of the theoretic criticisms of innomi-
nate artery endarterectomy through the years has
been the possibility of aortic dissection at the proxi-
mal site of the endarterectomy plane beginning
within the aorta. Ironically, the only reported deaths
from aortic dissection after innominate artery recon-
struction are both from supra-aortic grafting of the
innominate artery or its outflow vessels: the patient
reported herein and a patient included in the report
from Ohio State University.12 There may indeed be,
and probably are, other deaths from aortic dissection
after endarterectomy or grafting, either unrecog-
nized or unreported. In any event, aortic dissection
appears to be an uncommon, though greatly feared,
complication of great vessel reconstruction.
One of the most striking findings in our review was
the less than optimal outcome in patients documented
to have a hypercoagulable state, or thrombophilia. Of
seven early and late graft thromboses, four were in the
thrombophilic group. Of the six patients who were
documented to be thrombophilic, two had early symp-
tomatic graft thromboses with stroke. Of the four late
graft thromboses in our patients, two occurred in
patients with thrombophilia. Primary patency rates
were therefore adversely affected (Fig 4). Although the
secondary patency and stroke-free survival rates were
not statistically different from the rates of patients
without a known hypercoagulable state, there was a
trend downward in both categories. Most of these
patients only underwent diagnosis after their graft fail-
ures were manifested, only one of six (17%) having
undergone correct diagnosis before surgery. Only two
other patients underwent study for hypercoagulable
states. Therefore, we have no knowledge of the
denominator for patients with thrombophilia. This is
obviously a shortcoming of this retrospective study,
but the current cost of testing for thrombophilia is
prohibitive for routine use.
Should all patients who are scheduled for the
direct trans-sternal repair of great vessels undergo a
full thrombophilia workup? We think not, because the
cost of such an evaluation is not inconsiderable and
patients with thrombophilia would appear to repre-
sent a distinct minority of patients who undergo bra-
chiocephalic artery reconstruction. We do believe,
however, that either early or late graft/endarterecto-
my thrombosis, whether symptomatic or asympto-
matic, should prompt a full coagulation profile of
these patients. The patients with histories of previous
graft failures at these or other sites should undergo a
full evaluation before operation. Those patients so
identified should be maintained on life-long warfarin
sodium therapy.
The problems attendant to severe radiation to the
chest/neck in patients with RA are not easily
addressed. The problem is not the graft per se but its
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surrounding structures. The patient who had necro-
sis of the soft tissues of the neck develop, with lique-
faction of the strap muscles and severe radiation
injury to the larynx and esophagus as well, is a case in
point. The polyester limb in that neck was, of neces-
sity, removed. Sessa et al13 have reported the use of
harvested superficial femoral artery to replace carotid
arteries for patients with neck malignant disease. We
have replaced the innominate artery with superficial
femoral vein for a patient with infection. Whether an
autogenous limb constructed of superficial femoral
vein or superficial femoral artery would survive in the
milieu of soft tissue necrosis is unknown. This is a
group of patients for whom endovascular approaches
may hold great promise and certainly hold appeal.
Extensive disease for the full length of the common
carotid arteries may mitigate against that approach in
some patients.
The patient who died of the infected sternotomy
wound had an intact, clinically uninfected graft.
Whether autogenous reconstruction or angioplas-
ty/stenting would have altered that course, too, is
unknown. Nonetheless, the absence of prosthetic
materials in such patients would allow more options,
and most obviously, a patient who would undergo a
remote endovascular repair would not be subject to
late sternotomy necrosis and infection.
Our experience with these patients runs counter
to reports in the vascular literature for radiation injury
to the carotid, subclavian, and axillary arteries from
other institutions.14-17 McCready et al14 reported
three patients with RA to the common, internal, and
external carotid arteries who underwent successful
treatment without long-term complications. Mellière
et al17 reported seven patients with RA of the carotid
arteries and four patients with RA of the subclavian or
axillary arteries who underwent successful treatment
with operation or angioplasty without long-term
infection. Interestingly, three of 13 patients who were
managed for aortoiliac RA in that series had late infec-
tion develop. Andros et al16 reported nine patients
with carotid RA and seven with subclavian-axillary RA
who underwent successful treatment with operation.
There were no late infectious or necrotic problems in
a follow-up period of 48 months. Francfort et al15
reported no late problems in their patients nor found
any in their review of the literature. None of the
patients in these reports had median sternotomy or
aortic-origin reconstructions.
There is no literature detailing the risk of sternal
infection after sternotomy in an irradiated field.
Nonetheless, when infection develops in such
patients, the problem is especially challenging. The
pectoralis major muscle and other chest wall muscles
normally used for reconstruction in these patients
are often compromised by radiation injury to their
vasculature, making reconstruction difficult.18
Endovascular therapy may prove to be the pre-
ferred method of treatment for some of these patients.
It is most appealing in theory for the patients with
renal insufficiency or RA, if symptomatology and
anatomy will allow. Such therapy is not so intrinsically
appealing for patients with thrombophilia, although
we can find no literature addressed to this problem per
se. Sites of angioplasty and stenting in such patients
may prove to have unacceptably high rates of post-pro-
cedural thrombosis. Similarly, long extra-anatomic
bypass grafts, such as axillary-axillary artery bypass
grafts, may be even more prone to thrombotic occlu-
sion than direct in-line reconstructions. If identified
before surgery, this difficult group of patients should
have clear-cut symptoms not amenable to antiplatelet
or anticoagulant therapy before being offered either
surgical or radiologic intervention. Certainly, patients
who are asymptomatic and thrombophilic should not
be offered intervention. Perioperative pharmacologic
treatment of their particular coagulation defect should
be optimized if early and late reconstruction failures
are to be avoided. As more data are generated con-
cerning these problematic subsets of patients, the best
methods of dealing with them should become evident.
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Dr Edouard Kieffer (Paris, France). I want to congrat-
ulate Dr Rhodes on a carefully studied and nicely present-
ed series of patients. It is not indeed a great surprise to any
of us to hear from you that chronic renal insufficiency,
thrombophilia, and radiation arteritis are risk factors for
early and late complications after direct reconstruction of
the great vessels. Instead of discussing these points, I
would like to make a few comments and ask you some
questions about more specific aspects of your presentation.
First, it was apparent from your manuscript that coro-
nary artery disease, as usual, was the most relevant risk factor
in atherosclerotic patients. You had 40 patients with athero-
sclerosis, 26 of them with known coronary artery disease.
Ten of the patients underwent simultaneous coronary artery
bypass grafting with one intraoperative death. More impor-
tantly, five of the six late deaths were from cardiac causes.
This clearly indicates a high prevalence of coronary artery
disease in these patients and brings me to my first question.
What is your current policy concerning the preoperative
workup of these patients? Do you advocate, as we do, rou-
tine coronary arteriography in atherosclerotic patients sched-
uled for direct reconstruction of the great vessels?
Second, in a large experience with Takayasu’s arteritis,
we have had several patients with postoperative cerebral
hyperperfusion syndrome, including cerebral edema,
headaches, seizures, cerebral hemorrhage, and stroke.
These patients all had one-stage reconstruction of multi-
ple lesions and low preoperative cerebral blood flow. My
impression is that this complication is much more preva-
lent in patients with Takayasu’s arteritis than in patients
with atherosclerosis who undergo treatment for similar
extensive lesions. Do you have any experience with this
complication, and could you comment on this?
You mentioned graft thrombosis in at least two
patients with aorta to external carotid artery bypass grafts.
For the most, we have abandoned this type of reconstruc-
tion, not only because of a high risk of early or late occlu-
sion, but also because of the relatively low benefit to the
patient. Although not statistically significant, you had the
lower 3-year patency rate in patients with Takayasu’s
arteritis. What were the specific types of reconstruction
performed in this particular group of patients? 
Another specific problem in patients with Takayasu’s
arteritis is that some of them have thick, heavily diseased,
sometimes calcified, ascending aortas. We have tried to
identify these patients before surgery with computed
tomographic scanning, magnetic resonance imaging, or
transesophageal echocardiography and have managed
them in several ways, such as replacing the ascending aorta
in some patients. But most often we managed with bypass
grafting from the descending thoracic aorta, the supraceli-
ac aorta, or the aortoiliac system.
These remote bypass grafts may also be of value in
managing the unusual patient with radiation arteritis and
major thoracic cutaneous changes and bony necrosis. This,
along with the use of autogenous conduits, might have
been a valuable alternative to prevent infection in your
three patients.
Again, Dr Rhodes, thank you for bringing to us this
information on an interesting field of vascular surgery. I
thank the Society for the privilege of discussing this paper.
Thank you.
Dr Kenneth J. Cherry, Jr. Thank you, Dr Kieffer.
The first question was concerning our evaluation of
the patients’ cardiac function. Unlike you, we do not per-
form routine coronary angiography in all patients. But all
patients, whether they have atherosclerosis obliterans,
Takayasu’s, or radiation arthritis, undergo a physiologic
evaluation. And if those results are positive, then the
patient will undergo a cardiac catheterization.
Your second question concerned hyperperfusion. And
we have seen that more commonly in patients with
DISCUSSION
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 2 Rhodes et al 269
Takayasu’s, just as you have. Because of work you have done
and work that has been done by the neurosurgeons at the
Mayo Clinic, we are particularly sensitive to that and we do
everything we can to keep the patient’s blood pressure in
good control.
The third question concerned bypass grafts to the
external carotid artery and their relative futility. We would
probably agree. The patient with the external carotid
occlusions was a patient with Takayasu’s. He had under-
gone operation elsewhere, and the reconstructions to the
common and internal carotid arteries done at those places
had failed. Those were the only outflow vessels left in that
particular patient. 
Your fourth question concerned the thick aortas, and
we have seen that. One of the patients who underwent
concomitant reconstruction underwent replacement of
the ascending and arch aorta in large part because of that
thickness. We have not had to go to the descending aorta,
but we do worry about it. 
Thank you.
